To explore the intricacies of the manipulation of abuse deterrent formulations (ADFs) in the clinical pharmacology unit (CPU) and its relationship to in vitro studies.
Neurology Central talks to John Hardy (University College London, UK) following his recent receival of the Breakthrough Prize in Life Sciences.
The new KERUS platform developed by Exploristics fills a gap in the market for a software package capable of generating and evaluating virtual research studies, without the need for a technical knowledge of mathematical modeling. This unique simulation platform is designed specifically to give study simulations involving multiple correlated outcomes. Multiple trial scenarios can be examined in silico allowing researchers to focus on trial scenarios with the highest chance of success.
Neurology Central talks to Johan Vos, Deputy Executive Director of Alzheimer’s Disease International about the charity’s work and the key findings of the 2015 World Alzheimer Report.
In this video, Professor Cathy Price (Wellcome Trust Centre for Neuroimaging UCL, UK) provides us with an update on the PLORAS study, which focuses on predicting language outcome and recovery after stroke.